Growth Metrics

INVO Fertility (IVF) Gains from Sales and Divestitures (2019 - 2023)

INVO Fertility (IVF) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $16505.0 as the latest value for Q3 2023.

  • Quarterly Gains from Sales and Divestitures fell 87.91% to $16505.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was $16505.0 through Sep 2023, down 87.91% year-over-year, with the annual reading at $143174.0 for FY2022, 30.17% down from the prior year.
  • Gains from Sales and Divestitures for Q3 2023 was $16505.0 at INVO Fertility, roughly flat from $16505.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $1.2 million in Q1 2020, with the low at $2083.0 in Q4 2019.
  • Average Gains from Sales and Divestitures over 5 years is $147945.1, with a median of $71312.5 recorded in 2020.
  • The sharpest move saw Gains from Sales and Divestitures soared 2973.5% in 2020, then tumbled 97.89% in 2021.
  • Over 5 years, Gains from Sales and Divestitures stood at $2083.0 in 2019, then skyrocketed by 2973.5% to $64021.0 in 2020, then surged by 220.26% to $205031.0 in 2021, then crashed by 30.17% to $143174.0 in 2022, then crashed by 88.47% to $16505.0 in 2023.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $16505.0, $16505.0, and $179798.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.